Literature DB >> 17103008

[Primary nasal natural killer/T-cell lymphomas: classification and clinicopathological features].

A Sandner1, S Kösling, P Helmbold, M Winkler, M B Bloching, H-J Holzhausen.   

Abstract

BACKGROUND: Nasal NK/T-cell lymphomas are rare malignancies in Europe or North America. Histological diagnosis is difficult, because tumors imbedded in large necrotic areas and neoplastic infiltrates may be admixed with small lymphocytes, plasma cells, eosinophils, and histiocytes, and thus the process could be misdiagnosed as chronic inflammation. Progression of the disease leads to septal perforation and may also result in destruction of the hard palate, and if left untreated it ends fatally. This introduced the term "lethal midline granuloma", a term which should not be used any more.
MATERIAL AND METHODS: Clinical features, pathohistology, and current classification of primary nasal NK/T-cell lymphomas are described against the background of the recent literature and a case report.
RESULTS: Immunophenotyping is essential for the diagnosis. Tumor cells are uniformly infected by Epstein-Barr virus, which could be verified by EBER in situ hybridization. Immunohistochemically, tumor cells are positive for CD56, cytoplasmic CD3epsilon, and CD2 and they express cytotoxic molecules like granzyme B, TIA-1, GMP17, and perforin. Therapeutic options are radio- or radiochemotherapy. On average, 2- and 5-year survival rates of 50% are obtained in stages I and II. The prognosis of advanced tumor stages is very poor.
CONCLUSIONS: Immunohistochemical and molecular genetic early diagnosis is of crucial prognostic relevance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17103008     DOI: 10.1007/s00106-006-1470-z

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  37 in total

1.  Nasal T-cell/natural killer cell lymphoma: CT and MR imaging features of a new clinicopathologic entity.

Authors:  G C Ooi; C S Chim; R Liang; K W Tsang; Y L Kwong
Journal:  AJR Am J Roentgenol       Date:  2000-04       Impact factor: 3.959

2.  MR imaging of nasal T-cell/natural killer cell lymphoma.

Authors:  A D King; K I Lei; A T Ahuja; W W Lam; C Metreweli
Journal:  AJR Am J Roentgenol       Date:  2000-01       Impact factor: 3.959

3.  The pathology of malignant granuloma of the nose.

Authors:  I FRIEDMANN
Journal:  J Laryngol Otol       Date:  1955-05       Impact factor: 1.469

4.  Outcome of patients with nasal natural killer (NK)/T-cell lymphoma treated with radiotherapy, with or without chemotherapy.

Authors:  Ivan Weng Keong Tham; Khai Mun Lee; Swee Peng Yap; Susan Li-Er Loong
Journal:  Head Neck       Date:  2006-02       Impact factor: 3.147

5.  Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy.

Authors:  Jeeyun Lee; Yeon Hee Park; Won Seog Kim; Seung-Sook Lee; Baek-Yeol Ryoo; Sung Hyun Yang; Keon Woo Park; Jung Hoon Kang; Joon Oh Park; Se Hoon Lee; Kihyun Kim; Chul Won Jung; Young Suk Park; Young-Hyuck Im; Won Ki Kang; Mark H Lee; Young H Ko; Yong Chan Ahn; Keunchil Park
Journal:  Eur J Cancer       Date:  2005-07       Impact factor: 9.162

6.  Lethal midline granuloma with a novel T-cell phenotype as found in peripheral T-cell lymphoma.

Authors:  S M Lippman; T M Grogan; C M Spier; C F Koopmann; E P Gall; D S Shimm; B G Durie
Journal:  Cancer       Date:  1987-03-01       Impact factor: 6.860

Review 7.  Midfacial necrotizing lesions.

Authors:  J G Batsakis; M A Luna
Journal:  Semin Diagn Pathol       Date:  1987-05       Impact factor: 3.464

8.  [Nasal T-cell lymphoma of the lethal midline type. Case report and current aspects in the literature].

Authors:  D Ullrich; I Wildfang; J H Karstens; M Schröder
Journal:  HNO       Date:  1999-05       Impact factor: 1.284

9.  Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index.

Authors:  Chor-Sang Chim; Shing-Yan Ma; Wing-Yan Au; Carolyn Choy; Albert K W Lie; Raymond Liang; Chun-Chung Yau; Yok-Lam Kwong
Journal:  Blood       Date:  2003-08-21       Impact factor: 22.113

10.  CD56 (NKH1)-positive hematolymphoid malignancies: an aggressive neoplasm featuring frequent cutaneous/mucosal involvement, cytoplasmic azurophilic granules, and angiocentricity.

Authors:  K F Wong; J K Chan; C S Ng; K C Lee; W Y Tsang; M M Cheung
Journal:  Hum Pathol       Date:  1992-07       Impact factor: 3.466

View more
  2 in total

1.  [NK/T-cell lymphoma, nasal type with cutaneous dissemination].

Authors:  A M Baran; J Reifenberger; D Helbig
Journal:  Hautarzt       Date:  2012-04       Impact factor: 0.751

2.  Nasal surgery in patients with systemic disorders.

Authors:  Florian Sachse; Wolfgang Stoll
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2011-04-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.